I respectfully disagree. Here's how the price action unfolded last week on an intra-day chart:
Conclusion? Bleeding has stopped, buyers are nibbling. If this current turn in momentum can push prices through the down TL and falling 50 day EMA, then I think we've seen the lows and hopefully some fire starts spurting out of AMRN's belly.
By the way, PBYI is a good example of manipulation, followed by massive buying in front of an FDA panel vote.
Perhaps AMRN missed by a penny for the same reason?